Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,713 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 686
Recruiting: 381
Ph III recruiting: 45
Growth YoY: +8.5%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (278)

clinicaltrialsPublishedShowing 101–150 of 1,713 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02750826	Breast Cancer WEight Loss Study (BWEL Study)	active not recruiting	Phase 3	3,177	Alliance for Clinical Trials in OncologyOTHER	4	Sep 2, 2026	clinicaltrials
NCT03317405	Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery	active not recruiting	Phase 1	32	National Cancer Institute (NCI)NIH	1	Sep 2, 2026	clinicaltrials